Literature DB >> 29391900

Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer.

Shikha Suman1, Ashutosh Mishra1.   

Abstract

Gene markers are crucial for cancer prognosis and treatment. Previous studies have placed greater emphasis on individual diagnostic genes, thereby ignoring systemic-level attributes across diseases. Female-specific cells namely, breast, endometrium, cervical, ovarian and vulvar cells are highly susceptible to cancer. To date, a limited number of molecular studies have been performed that evaluate common biological processes across gynecological types of cancer. Differentially expressed genes in breast, cervical, endometrial, vulvar and ovarian cancer were utilized to construct protein-protein interaction networks, and to identify a common module across the five cancer types. A single common module with 8 nodes and 26 edges was mined among the five cancer systems. In total, four hub genes were present across the five cancer gene sets. Genes in the common module were enriched for the common pathways and associated diseases. The aurora kinase pathway was revealed to be conserved across the five cancer types surveyed. The present study, therefore, revealed that the aurora kinase pathway has a crucial function in the pathogenesis of the five aforementioned gynecological types of cancer through cross-tumor conservation.

Entities:  

Keywords:  differentially expressed genes; hubs; module; protein-protein interaction network

Year:  2017        PMID: 29391900      PMCID: PMC5769420          DOI: 10.3892/ol.2017.7368

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  68 in total

Review 1.  Aurora kinase inhibitors as anticancer molecules.

Authors:  Hiroshi Katayama; Subrata Sen
Journal:  Biochim Biophys Acta       Date:  2010-09-20

2.  Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development.

Authors:  Y Luo; Y Wu; Y Peng; X Liu; J Bie; S Li
Journal:  Ir J Med Sci       Date:  2015-03-19       Impact factor: 1.568

3.  Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer.

Authors:  Brian Gabrielli; Fawzi Bokhari; Max V Ranall; Zay Yar Oo; Alexander J Stevenson; Weili Wang; Melanie Murrell; Mushfiq Shaikh; Sora Fallaha; Daniel Clarke; Madison Kelly; Karin Sedelies; Melinda Christensen; Sara McKee; Graham Leggatt; Paul Leo; Dubravka Skalamera; H Peter Soyer; Thomas J Gonda; Nigel A J McMillan
Journal:  Mol Cancer Ther       Date:  2015-10-29       Impact factor: 6.261

4.  ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.

Authors:  Liya Zhang; Shulan Zhang
Journal:  J Obstet Gynaecol Res       Date:  2010-12-15       Impact factor: 1.730

5.  Association of survivin gene polymorphism with endometrial cancer.

Authors:  Parisa Zahedi; Soheila Aminimoghaddam; Forough A Sayahpour; Vahid Haghpanah; Parvin Amiri; Forozandeh Fereidoni; Elnaz Mahrampour; Bagher Larijani; Javad Tavakkoly-Bazzaz; Mahsa M Amoli
Journal:  Int J Gynecol Cancer       Date:  2012-01       Impact factor: 3.437

6.  Expression of Aurora kinase A and B in normal and malignant cervical tissue: high Aurora A kinase expression in squamous cervical cancer.

Authors:  Nae-Fang Twu; Chiou-Chung Yuan; Ming-Shyen Yen; Chiung-Ru Lai; Kuan-Chong Chao; Peng-Hui Wang; Hua-Hsi Wu; Yi-Jen Chen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-12-06       Impact factor: 2.435

7.  Kinesin family member 20A is a novel melanoma-associated antigen.

Authors:  Junji Yamashita; Satoshi Fukushima; Masatoshi Jinnin; Noritoshi Honda; Katunari Makino; Keisuke Sakai; Shinichi Masuguchi; Yuji Inoue; Hironobu Ihn
Journal:  Acta Derm Venereol       Date:  2012-11       Impact factor: 4.437

Review 8.  Targeted cancer therapy.

Authors:  Charles Sawyers
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

9.  Identification of Biomarkers in Breast Cancer by Gene Expression Profiling Using Human Tissues.

Authors:  Junjie Fu; William Allen; Amy Xia; Zhuofan Ma; Xin Qi
Journal:  Genom Data       Date:  2014-12-01

10.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013.

Authors:  Jing Wang; Dexter Duncan; Zhiao Shi; Bing Zhang
Journal:  Nucleic Acids Res       Date:  2013-05-23       Impact factor: 16.971

View more
  5 in total

1.  Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.

Authors:  Sha Lv; Xiaoxiao Xu; Zhangying Wu
Journal:  Oncol Lett       Date:  2019-11-01       Impact factor: 2.967

Review 2.  Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency.

Authors:  Flavia Zita Francies; Sheynaz Bassa; Aristotelis Chatziioannou; Andreas Martin Kaufmann; Zodwa Dlamini
Journal:  Genes (Basel)       Date:  2021-01-20       Impact factor: 4.096

3.  Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach.

Authors:  Simran Venkatraman; Brinda Balasubramanian; Pisut Pongchaikul; Rutaiwan Tohtong; Somchai Chutipongtanate
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

4.  Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.

Authors:  Md Selim Reza; Md Harun-Or-Roshid; Md Ariful Islam; Md Alim Hossen; Md Tofazzal Hossain; Shengzhong Feng; Wenhui Xi; Md Nurul Haque Mollah; Yanjie Wei
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

5.  Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.

Authors:  Md Selim Reza; Md Alim Hossen; Md Harun-Or-Roshid; Mst Ayesha Siddika; Md Hadiul Kabir; Md Nurul Haque Mollah
Journal:  Discov Oncol       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.